FS 069
(QYSGYZVSCZSLHT-UHFFFAOYSA-N)
Structure
- SMILES
- FC(C(F)(F)F)(C(F)(F)F)F
- Type(s)
- Approved
- Molecular Formula:
- C3F8
- Molecular Weight:
- 188.019
- Log P:
- 2.7463
- Hydrogen Bond Acceptor:
- 0
- Hydrogen Bond Donor:
- 0
- TPSA:
- 0
- CAS Number(s):
- 76-19-7
Synonym(s)
1.
FS 069
2.
FS-069
3.
FS069
4.
Optison
5.
perfluoropropane-filled albumin microsphere solution
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Back Pain | FAERS: 812 Canada Vigilance: 5 | Canada Vigilance SIDER US FAERS | |
| 2 | Flushing | FAERS: 125 | SIDER US FAERS | |
| 3 | Urticaria | FAERS: 118 | SIDER US FAERS | |
| 4 | Chest Pain | FAERS: 95 | OFFSIDES SIDER US FAERS | |
| 5 | Headache | FAERS: 89 | SIDER US FAERS | |
| 6 | Dizziness | FAERS: 70 Canada Vigilance: 3 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 7 | Nausea | FAERS: 61 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 8 | Pruritus | FAERS: 54 | SIDER US FAERS | |
| 9 | Arthralgia | FAERS: 47 | SIDER US FAERS | |
| 10 | Neck Pain | FAERS: 44 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 11 | Musculoskeletal Pain | FAERS: 40 Canada Vigilance: 1 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 12 | Chest discomfort | FAERS: 35 | US FAERS | |
| 13 | Erythema | FAERS: 33 | OFFSIDES SIDER US FAERS | |
| 14 | Hypersensitivity | FAERS: 33 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 15 | Hypotension | FAERS: 33 | SIDER US FAERS | |
| 16 | Pain | FAERS: 32 | SIDER US FAERS | |
| 17 | Cardiac Arrest | FAERS: 27 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 18 | Drug ineffective | FAERS: 27 | US FAERS | |
| 19 | Flank Pain | FAERS: 25 | OFFSIDES SIDER US FAERS | |
| 20 | Feeling abnormal | FAERS: 23 | OFFSIDES SIDER US FAERS | |
| 21 | Syncope | FAERS: 22 | SIDER US FAERS | |
| 22 | Tachycardia | FAERS: 20 | SIDER US FAERS | |
| 23 | Unresponsive to stimuli | FAERS: 18 | US FAERS | |
| 24 | Vomiting | FAERS: 18 | SIDER US FAERS | |
| 25 | Contrast media reaction | FAERS: 17 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 26 | Respiratory arrest | FAERS: 17 | SIDER US FAERS | |
| 27 | Malaise | FAERS: 16 | SIDER US FAERS | |
| 28 | Product preparation error | FAERS: 16 | US FAERS | |
| 29 | Tremor | FAERS: 15 | SIDER US FAERS | |
| 30 | No adverse event | FAERS: 14 | US FAERS | |
| 31 | Renal pain | FAERS: 14 | SIDER US FAERS | |
| 32 | Ventricular Fibrillation | FAERS: 13 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 33 | Bradycardia | FAERS: 12 | SIDER US FAERS | |
| 34 | Burning sensation | FAERS: 12 | SIDER US FAERS | |
| 35 | Cyanosis | FAERS: 12 | US FAERS | |
| 36 | Atrial Fibrillation | FAERS: 11 | SIDER US FAERS | |
| 37 | Throat irritation | FAERS: 11 | SIDER US FAERS | |
| 38 | Anxiety | FAERS: 10 | US FAERS | |
| 39 | Dysgeusia | FAERS: 10 | SIDER US FAERS | |
| 40 | Lip swelling | FAERS: 10 | SIDER US FAERS | |
| 41 | Palpitations | FAERS: 10 | SIDER US FAERS | |
| 42 | Respiratory distress | FAERS: 10 | SIDER US FAERS | |
| 43 | Abdominal Pain | FAERS: 9 | SIDER US FAERS | |
| 44 | Musculoskeletal discomfort | FAERS: 8 | OFFSIDES SIDER US FAERS | |
| 45 | Product quality issue | FAERS: 8 | US FAERS | |
| 46 | Wheezing | FAERS: 8 | SIDER US FAERS | |
| 47 | Asthenia | FAERS: 7 | SIDER US FAERS | |
| 48 | Hypoxia | FAERS: 7 | US FAERS | |
| 49 | Pallor | FAERS: 7 | US FAERS | |
| 50 | Pelvic Pain | FAERS: 7 | US FAERS | |
| 51 | Sinus Tachycardia | FAERS: 7 | US FAERS | |
| 52 | Bronchospasm | FAERS: 6 | SIDER US FAERS | |
| 53 | Discomfort | FAERS: 6 | SIDER US FAERS | |
| 54 | Ejection Fraction Decreased | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 55 | Presyncope | FAERS: 6 | US FAERS | |
| 56 | Anaphylactoid Reaction | FAERS: 5 | SIDER US FAERS | |
| 57 | Fatigue | FAERS: 5 | SIDER US FAERS | |
| 58 | Musculoskeletal stiffness | FAERS: 5 | US FAERS | |
| 59 | Myalgia | FAERS: 5 | SIDER US FAERS | |
| 60 | Abdominal discomfort | FAERS: 4 | OFFSIDES US FAERS | |
| 61 | Agitation | FAERS: 4 | SIDER US FAERS | |
| 62 | Anaphylactic shock | FAERS: 4 | SIDER US FAERS | |
| 63 | Chills | FAERS: 4 | SIDER US FAERS | |
| 64 | Dyspepsia | FAERS: 4 | SIDER US FAERS | |
| 65 | Infusion Site Extravasation | FAERS: 4 | US FAERS | |
| 66 | Injection site extravasation | FAERS: 4 | US FAERS | |
| 67 | Injection site pain | FAERS: 4 | SIDER US FAERS | |
| 68 | Limb discomfort | FAERS: 4 | US FAERS | |
| 69 | Muscle Rigidity | FAERS: 4 | US FAERS | |
| 70 | Muscle tightness | FAERS: 4 | US FAERS | |
| 71 | Myocardial Infarction | FAERS: 4 | US FAERS | |
| 72 | Retching | FAERS: 4 | US FAERS | |
| 73 | Supraventricular tachycardia | FAERS: 4 | SIDER US FAERS | |
| 74 | Adverse event | FAERS: 3 | US FAERS | |
| 75 | Blood glucose increased | FAERS: 3 | US FAERS | |
| 76 | Cerebrovascular accident | FAERS: 3 | US FAERS | |
| 77 | Cold sweat | FAERS: 3 | US FAERS | |
| 78 | Feeling Cold | FAERS: 3 | US FAERS | |
| 79 | Head discomfort | FAERS: 3 | US FAERS | |
| 80 | Hyperventilation | FAERS: 3 | US FAERS | |
| 81 | Nervousness | FAERS: 3 | US FAERS | |
| 82 | Rash erythematous | FAERS: 3 | SIDER US FAERS | |
| 83 | Swelling | FAERS: 3 | SIDER US FAERS | |
| 84 | Vasospasm | FAERS: 3 | OFFSIDES US FAERS | |
| 85 | Angioedema | FAERS: 2 | SIDER US FAERS | |
| 86 | Atelectasis | FAERS: 2 | US FAERS | |
| 87 | Bladder pain | FAERS: 2 | US FAERS | |
| 88 | Blood creatine increased | FAERS: 2 | US FAERS | |
| 89 | Bone pain | FAERS: 2 | US FAERS | |
| 90 | Choking | FAERS: 2 | US FAERS | |
| 91 | Circumstance or information capable of leading to medication error | FAERS: 2 | US FAERS | |
| 92 | Depressed Level of Consciousness | FAERS: 2 | US FAERS | |
| 93 | Disorientation | FAERS: 2 | US FAERS | |
| 94 | Dysphonia | FAERS: 2 | US FAERS | |
| 95 | Extravasation | FAERS: 2 | US FAERS | |
| 96 | Eye irritation | FAERS: 2 | US FAERS | |
| 97 | Immediate post-injection reaction | FAERS: 2 | US FAERS | |
| 98 | Incontinence | FAERS: 2 | US FAERS | |
| 99 | Infusion site swelling | FAERS: 2 | OFFSIDES US FAERS | |
| 100 | Lymphadenopathy | FAERS: 2 | SIDER US FAERS | |
| 101 | Occupational exposure to product | FAERS: 2 | US FAERS | |
| 102 | Oropharyngeal discomfort | FAERS: 2 | US FAERS | |
| 103 | Peripheral swelling | FAERS: 2 | US FAERS | |
| 104 | Pharyngolaryngeal Pain | FAERS: 2 | US FAERS | |
| 105 | Pneumonia | FAERS: 2 | US FAERS | |
| 106 | Post procedural complication | FAERS: 2 | US FAERS | |
| 107 | Restlessness | FAERS: 2 | US FAERS | |
| 108 | Sciatica | FAERS: 2 | US FAERS | |
| 109 | Seizure like phenomena | FAERS: 2 | US FAERS | |
| 110 | Shock | FAERS: 2 | SIDER US FAERS | |
| 111 | Staring | FAERS: 2 | US FAERS | |
| 112 | Tonic clonic movements | FAERS: 2 | OFFSIDES US FAERS | |
| 113 | Visual disturbance | FAERS: 2 | SIDER US FAERS | |
| 114 | Acute myocardial infarction | FAERS: 1 | SIDER US FAERS | |
| 115 | Acute respiratory failure | FAERS: 1 | US FAERS | |
| 116 | Altered state of consciousness | FAERS: 1 | US FAERS | |
| 117 | Angina Pectoris | FAERS: 1 | US FAERS | |
| 118 | Blood pressure fluctuation | FAERS: 1 | US FAERS | |
| 119 | Blood pressure immeasurable | FAERS: 1 | US FAERS | |
| 120 | Blood urine present | FAERS: 1 | US FAERS | |
| 121 | Cardiac complication associated with device | FAERS: 1 | US FAERS | |
| 122 | Cardiac procedure complication | FAERS: 1 | US FAERS | |
| 123 | Cheilitis | FAERS: 1 | US FAERS | |
| 124 | Chest wall pain | FAERS: 1 | US FAERS | |
| 125 | Crying | FAERS: 1 | US FAERS | |
| 126 | Decorticate posture | FAERS: 1 | US FAERS | |
| 127 | Dehydration | FAERS: 1 | US FAERS | |
| 128 | Diplegia | FAERS: 1 | US FAERS | |
| 129 | Dreamy state | FAERS: 1 | US FAERS | |
| 130 | Drug administration error | FAERS: 1 | US FAERS | |
| 131 | Drug ineffective for unapproved indication | FAERS: 1 | US FAERS | |
| 132 | Drug label confusion | FAERS: 1 | US FAERS | |
| 133 | Dysphasia | FAERS: 1 | US FAERS | |
| 134 | Electrocardiogram abnormal | FAERS: 1 | SIDER US FAERS | |
| 135 | Electromechanical dissociation | FAERS: 1 | US FAERS | |
| 136 | Endotracheal intubation complication | FAERS: 1 | US FAERS | |
| 137 | Epistaxis | FAERS: 1 | US FAERS | |
| 138 | Escherichia sepsis | FAERS: 1 | US FAERS | |
| 139 | Expired product administered | FAERS: 1 | US FAERS | |
| 140 | Exposure during breast feeding | FAERS: 1 | US FAERS | |
| 141 | Eyelid Function Disorder | FAERS: 1 | US FAERS | |
| 142 | Facial Pain | FAERS: 1 | US FAERS | |
| 143 | Feeling jittery | FAERS: 1 | US FAERS | |
| 144 | Gastrointestinal sounds abnormal | FAERS: 1 | US FAERS | |
| 145 | General physical health deterioration | FAERS: 1 | US FAERS | |
| 146 | Glaucoma | FAERS: 1 | US FAERS | |
| 147 | Heart sounds abnormal | FAERS: 1 | US FAERS | |
| 148 | Hypoaesthesia facial | FAERS: 1 | OFFSIDES US FAERS | |
| 149 | Incorrect route of product administration | FAERS: 1 | US FAERS | |
| 150 | Infusion site pain | FAERS: 1 | US FAERS | |
| 151 | Injection Site Reaction | FAERS: 1 | SIDER US FAERS | |
| 152 | Injection related reaction | FAERS: 1 | US FAERS | |
| 153 | Injection site erythema | FAERS: 1 | US FAERS | |
| 154 | Injection site urticaria | FAERS: 1 | US FAERS | |
| 155 | Intercepted drug dispensing error | FAERS: 1 | US FAERS | |
| 156 | Lack of spontaneous speech | FAERS: 1 | US FAERS | |
| 157 | Left Ventricular Hypertrophy | FAERS: 1 | US FAERS | |
| 158 | Lethargy | FAERS: 1 | US FAERS | |
| 159 | Lower respiratory tract congestion | FAERS: 1 | US FAERS | |
| 160 | Maternal exposure during breast feeding | FAERS: 1 | US FAERS | |
| 161 | Musculoskeletal chest pain | FAERS: 1 | US FAERS | |
| 162 | Mydriasis | FAERS: 1 | US FAERS | |
| 163 | Myoclonus | FAERS: 1 | US FAERS | |
| 164 | Neurological examination abnormal | FAERS: 1 | OFFSIDES US FAERS | |
| 165 | Non-cardiac chest pain | FAERS: 1 | US FAERS | |
| 166 | Oropharyngeal pain | FAERS: 1 | US FAERS | |
| 167 | Papule | FAERS: 1 | US FAERS | |
| 168 | Paraplegia | FAERS: 1 | US FAERS | |
| 169 | Pelvic discomfort | FAERS: 1 | OFFSIDES US FAERS | |
| 170 | Penile swelling | FAERS: 1 | US FAERS | |
| 171 | Pericarditis | FAERS: 1 | US FAERS | |
| 172 | Piloerection | FAERS: 1 | US FAERS | |
| 173 | Procedural complication | FAERS: 1 | US FAERS | |
| 174 | Product dosage form issue | FAERS: 1 | US FAERS | |
| 175 | Productive Cough | FAERS: 1 | US FAERS | |
| 176 | Pulmonary pain | FAERS: 1 | US FAERS | |
| 177 | Purpura | FAERS: 1 | US FAERS | |
| 178 | Respiratory Failure | FAERS: 1 | US FAERS | |
| 179 | Rosacea | FAERS: 1 | US FAERS | |
| 180 | Screaming | FAERS: 1 | US FAERS | |
| 181 | Sensation of blood flow | FAERS: 1 | US FAERS | |
| 182 | Sneezing | FAERS: 1 | US FAERS | |
| 183 | Somnolence | FAERS: 1 | US FAERS | |
| 184 | Streptococcus test | FAERS: 1 | US FAERS | |
| 185 | Stress | FAERS: 1 | US FAERS | |
| 186 | Stridor | FAERS: 1 | SIDER US FAERS | |
| 187 | Subcutaneous nodule | FAERS: 1 | US FAERS | |
| 188 | Tardive Dyskinesia | FAERS: 1 | US FAERS | |
| 189 | Tension Headache | FAERS: 1 | US FAERS | |
| 190 | Thirst | FAERS: 1 | US FAERS | |
| 191 | Thrombocytopenia | FAERS: 1 | US FAERS | |
| 192 | Troponin increased | FAERS: 1 | US FAERS | |
| 193 | Unevaluable event | FAERS: 1 | US FAERS | |
| 194 | Urinary Incontinence | FAERS: 1 | US FAERS | |
| 195 | Urine output increased | FAERS: 1 | US FAERS | |
| 196 | Vascular Access Complication | FAERS: 1 | US FAERS | |
| 197 | Vertigo | FAERS: 1 | SIDER US FAERS | |
| 198 | Visual Impairment | FAERS: 1 | SIDER US FAERS | |
| 199 | Visual tracking test abnormal | FAERS: 1 | US FAERS | |
| 200 | Abnormal vision | SIDER | ||
| 201 | Accidental exposure | OFFSIDES | ||
| 202 | Airway edema | SIDER | ||
| 203 | Albuminuria | SIDER | ||
| 204 | Blood and lymphatic system disorders | SIDER | ||
| 205 | Blood creatinine increased | Canada Vigilance: 1 | Canada Vigilance | |
| 206 | Choking sensation | OFFSIDES | ||
| 207 | Chromaturia | OFFSIDES | ||
| 208 | Conjunctival deposit | OFFSIDES | ||
| 209 | Conjunctivitis | SIDER | ||
| 210 | Cramps of lower extremities | SIDER | ||
| 211 | Dermatitis | SIDER | ||
| 212 | Drug withdrawal headache | OFFSIDES | ||
| 213 | Dry skin | SIDER | ||
| 214 | Eosinophilia | SIDER | ||
| 215 | Exposure to chemical pollution | OFFSIDES | ||
| 216 | Formication | OFFSIDES | ||
| 217 | Gastrointestinal Pain | SIDER | ||
| 218 | Granulocytosis | SIDER | ||
| 219 | Induration | SIDER | ||
| 220 | Influenza-like symptoms | SIDER | ||
| 221 | Infusion site urticaria | OFFSIDES | ||
| 222 | Injection site discomfort | SIDER | ||
| 223 | Intention tremor | OFFSIDES | ||
| 224 | Leukocytosis | SIDER | ||
| 225 | Leukopenia | SIDER | ||
| 226 | Monocytosis | SIDER | ||
| 227 | Monoplegia | OFFSIDES | ||
| 228 | Pharyngitis | SIDER | ||
| 229 | Photophobia | SIDER | ||
| 230 | Rhinitis | SIDER | ||
| 231 | Serum Sickness | OFFSIDES | ||
| 232 | Tinnitus | SIDER | ||
| 233 | Toothache | SIDER | ||
| 234 | Ventricular arrhythmia | SIDER | ||
| 235 | anaphylaxis | 15488089 | CTD | |
| 236 | nervous system disorder | SIDER |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.